Absci Stock Gains Momentum as JPMorgan Initiates Coverage with Overweight Rating
Absci Stock In the fast-moving world of biotechnology, few names have been catching attention quite like Absci Corp. (NASDAQ: ABSI). Investors and analysts alike have been closely watching this AI-powered drug discovery company, and now, JPMorgan has added fuel to the growing excitement. On October 2, 2025, the investment bank officially initiated coverage on Absci … Read more